By age 80, the cumulative risk of breast cancer was 30% (95% CI 16% to 41%) for ATM PTV carriers and 25% (19% to 30%) for CHEK2 PTV carriers, compared with 12% in the general population. Here, CHEK2 is linked to breast cancer.